Pursuant to the provisions of regulation 30 read with clause 7 of para A of part A of Schedule III of the Listing Regulations, Zydus Lifesciences has informed that S. Diwanji (DIN: 00032072) ceased as the Director (including as the Independent Director) effective Tuesday, May 12, 2026, consequent upon completion of his tenure. The Company places on record its sincere appreciation for the valuable contributions made by Diwanji during his tenure. The Company also expressed its gratitude for Diwanji’s dedication, integrity, and professional expertise, which have enriched deliberations and decision-making processes. The requisite details as per the SEBI Master Circular are attached as Annexure – ‘A’.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1779.35 |
| Dr. Reddys Lab | 1267.05 |
| Cipla | 1397.75 |
| Zydus Lifesciences | 1085.45 |
| Lupin | 2248.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: